U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533929) titled 'Incidence and Predictors of Elevated ALT in Postpartum CHB Mothers' on April 09.
Brief Summary: China currently has about 86 million people with chronic hepatitis B virus infection, and infections caused by mother-to-child transmission account for 40% to 50% of new hepatitis B infections. Domestic and international guidelines both recommend that for pregnant women with high viral loads at 24-28 weeks of gestation, oral antiviral therapy should be administered based on a balance of risks and benefits and informed consent, continuing until after delivery, which can significantly reduce the rate of HBV mother-to-child transmission. St...